Zobrazeno 1 - 10
of 304
pro vyhledávání: '"Fossati R"'
Autor:
McCormack, M, Whitmarsh, K, Allerton, R, Gregory, D, Symonds, P, Hoskin, PJ, Adusumalli, M, Anand, A, Wade, R, Stewart, A, Taylor, W, Lutgens, LCHW, Hollema, H, Pras, E, Snyers, A, Westerveld, GH, Jobsen, JJ, Slot, A, Mens, JM, Stam, TC, Van Triest, B, Van der Steen-Banasik, EM, De Winter, KAJ, Quinn, MA, Kolodziej, I, Pyman, J, Johnson, C, Capp, A, Fossati, R, Colombo, A, Carinelli, S, Ferrero, A, Artioli, G, Davidson, C, McLachlin, CM, Ghatage, P, Rittenberg, PVC, Souhami, L, Thomas, G, Duvillard, P, Berton-Rigaud, D, Tubiana-Mathieu, N, de Boer, Stephanie M *, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B, Ledermann, Jonathan A, Khaw, Pearly, D'Amico, Romerai, Fyles, Anthony, Baron, Marie-Helene, Jürgenliemk-Schulz, Ina M, Kitchener, Henry C, Nijman, Hans W, Wilson, Godfrey, Brooks, Susan, Gribaudo, Sergio, Provencher, Diane, Hanzen, Chantal, Kruitwagen, Roy F, Smit, Vincent T H B M, Singh, Naveena, Do, Viet, Lissoni, Andrea, Nout, Remi A, Feeney, Amanda, Verhoeven-Adema, Karen W, Putter, Hein, Creutzberg, Carien L
Publikováno v:
In The Lancet Oncology September 2019 20(9):1273-1285
Autor:
INOVATYON study group, Colombo, N., Gadducci, A., Sehouli, J., Rulli, E., Mäenpää, J., Sessa, C., Montes, A., Ottevanger, N. B., Berger, R., Vergote, I., D'Incalci, M., Churruca Galaz, C., Chekerov, R., Nyvang, G. B., Riniker, S., Herbertson, R., Fossati, R., Barretina-Ginesta, M. P., Deryal, M., Mirza, M. R., Biagioli, E., Iglesias, M., Funari, G., Romeo, M., Tasca, G., Pardo, B., Tognon, G., Rubio-Pérez, M. J., DeCensi, A., De Giorgi, U., Zola, P., Benedetti Panici, P., Aglietta, M., Arcangeli, V., Zamagni, C., Bologna, A., Westermann, A., Heinzelmann-Schwarz, V., Tsibulak, I., Wimberger, P., Poveda, A.
Publikováno v:
British Journal of Cancer, 128, 1503-1513
British Journal of Cancer, 128, 8, pp. 1503-1513
British Journal of Cancer, 128, 8, pp. 1503-1513
Background This trial investigated the hypothesis that the treatment with trabectedin/PLD (TP) to extend the platinum-free interval (TFIp) can improve overall survival (OS) in patients with recurrent ovarian cancer (OC). Methods Patients with OC (up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d614c2a7ed8f0a9a0d08a180564fbbf
http://hdl.handle.net/2066/291764
http://hdl.handle.net/2066/291764
Autor:
Rosati, G., Ambrosini, G., Barni, S., Andreoni, B., Corradini, G., Luchena, G., Daniele, B., Gaion, F., Oliverio, G., Duro, M., Martignoni, G., Pinna, N., Sozzi, P., Pancera, G., Solina, G., Pavia, G., Pignata, S., Johnson, F., Labianca, R., Apolone, G., Zaniboni, A., Monteforte, M., Negri, E., Torri, V., Mosconi, P., Fossati, R. *
Publikováno v:
In Annals of Oncology February 2016 27(2):274-280
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Collinson, F., Qian, W., Fossati, R., Lissoni, A., Williams, C., Parmar, M. *, Ledermann, J., Colombo, N., Swart, A.
Publikováno v:
In Annals of Oncology June 2014 25(6):1165-1171
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lissoni, A.A., Colombo, N., Pellegrino, A., Parma, G., Zola, P., Katsaros, D., Chiari, S., Buda, A., Landoni, F., Peiretti, M., Dell’Anna, T., Fruscio, R., Signorelli, M., Grassi, R., Floriani, I., Fossati, R. *, Torri, V., Rulli, E.
Publikováno v:
In Annals of Oncology April 2009 20(4):660-665
Autor:
Marchini, S. *, Marabese, M., Marrazzo, E., Mariani, P., Cattaneo, D., Fossati, R., Compagnoni, A., Fruscio, R., Lissoni, A.A., Broggini, M.
Publikováno v:
In Annals of Oncology March 2008 19(3):501-507
Autor:
Colombo, N., Gadducci, A., Sehouli, J., Biagioli, E., Nyvang, G-B., Riniker, S., Montes, A., Ottevanger, N., Zeimet, A. G. G., Vergote, I. B., Funari, G., Baldoni, A., Tognon, G., De Censi, A., Churruca Galaz, C., Chekerov, R., Maenpaa, J., Rulli, E., Fossati, R., Poveda, A.
Publikováno v:
Colombo, N, Gadducci, A, Sehouli, J, Biagioli, E, Nyvang, G-B, Riniker, S, Montes, A, Ottevanger, N, Zeimet, A G G, Vergote, I B, Funari, G, Baldoni, A, Tognon, G, De Censi, A, Churruca Galaz, C, Chekerov, R, Maenpaa, J, Rulli, E, Fossati, R & Poveda, A 2020, ' INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line ', Annals of Oncology, vol. 31, no. Suppl. 4, LBA30, pp. S1161 . https://doi.org/10.1016/j.annonc.2020.08.2260
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::03bf789d3834a246b705faabb822c34e
https://portal.findresearcher.sdu.dk/da/publications/b7581da9-200a-4387-b5b0-a2496ad4f023
https://portal.findresearcher.sdu.dk/da/publications/b7581da9-200a-4387-b5b0-a2496ad4f023
Autor:
de Boer S. M., Powell M. E., Mileshkin L., Katsaros D., Bessette P., Haie-Meder C., Ottevanger P. B., Ledermann J. A., Khaw P., Colombo A., Fyles A., Baron M. -H., Jurgenliemk-Schulz I. M., Kitchener H. C., Nijman H. W., Wilson G., Brooks S., Carinelli S., Provencher D., Hanzen C., Lutgens L. C. H. W., Smit V. T. H. B. M., Singh N., Do V., D'Amico R., Nout R. A., Feeney A., Verhoeven-Adema K. W., Putter H., Creutzberg C. L., McCormack M., Whitmarsh K., Allerton R., Gregory D., Symonds P., Hoskin P. J., Adusumalli M., Anand A., Wade R., Stewart A., Taylor W., Kruitwagen R. F. P. M., Hollema H., Pras E., Snyers A., Stalpers L., Jobsen J. J., Slot A., Mens J. -W. M., Stam T. C., Van Triest B., Van der Steen - Banasik E. M., De Winter K. A. J., Quinn M. A., Kolodziej I., Pyman J., Johnson C., Capp A., Fossati R., Gribaudo S., Lissoni A. A., Ferrero A., Artioli G., Davidson C., McLachlin C. M., Ghatage P., Rittenberg P. V. C., Souhami L., Thomas G., Duvillard P., Berton-Rigaud D., Tubiana-Mathieu N.
Background: Although women with endometrial cancer generally have a favourable prognosis, those with high-risk disease features are at increased risk of recurrence. The PORTEC-3 trial was initiated to investigate the benefit of adjuvant chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c059f44413e24aad8161bbc27656bb61
https://hdl.handle.net/2318/1904372
https://hdl.handle.net/2318/1904372